Analysed ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) News Sources
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
01-04-2026
yahoo.com
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
02-02-2026
yahoo.com
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
18-12-2025
yahoo.com
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
15-09-2025
yahoo.com
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states
27-08-2025
yahoo.com
What is the current price of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The current price of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is $0.0316.
ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) since the previous trading day is $0.
ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The most recent average sentiment score for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The most recent sentiment for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is .
SEC-8K** Filing Available For ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.